Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...
Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...
Boston Scientific announced won CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results